Treatment decision-making process for Hodgkin’s lymphoma

1. BUSINESS OBJECTIVES

Our client was developing a new treatment for Hodgkin’s lymphoma (HL). It was necessary to understand the HL treatment decision-making process and uncover the factors that drive treatment choice and trigger changes in first-line treatment. The client was also looking to identify the most compelling reasons/benefits to best support the uptake of their product as a new first-line indication.

2. BAZIS AMERICAS SOLUTION

Our team conducted face-to-face interviews with onco-hematologists. In-depth interviews with key opinion leaders were pivotal to understanding the overall opportunity and value proposition for the client’s product as a new first-line indication for HL.

3. CLIENT IMPACT

Based on the findings, our client received clarity on Hodgkin’s lymphoma treatment approaches, goals, unmet needs, and value perceptions for current treatment options. Our solution helped find the best future positioning of the product as a HL treatment.